In the three groups, patients with elevated cTnI level showed no difference in stroke subtypes, although comparisons of normal and elevated cTnI levels (< 0.03 vs. > 0.03 μg/L) demonstrated a trend of differences between them (p = 0.067). This evidence concerns the gene TNNI3 and stroke disorder.